Literature DB >> 15356973

Progressive nephropathy associated with mitochondrial tRNA gene mutation.

D Dinour1, S Mini, S Polak-Charcon, D Lotan, E J Holtzman.   

Abstract

Mitochondrial DNA plays a crucial role in oxidative production of energy. Thus, defects in mitochondrial DNA can affect virtually all organ systems. The point mutation A --> G at position 3243 in the mitochondrial tRNAleu(UUR) gene is the cause of several distinct types of mitochondrial cytopathy and several clinical phenotypes, including encephalomyopathy with lactic acidosis and stroke-like episodes and maternally inherited diabetes and deafness. This mutation has been recently described also in association with kidney disease, mainly focal and segmental glomerulosclerosis. At present, little is known about the prevalence of this mitochondrial nephropathy, its clinical course and the pathogenesis of glomerular damage. We describe 2 unrelated patients, who presented with proteinuria and progressed to end-stage renal failure. Other clinical features were short stature, severe headache, hearing loss, diabetes mellitus and hypertrophic cardiomyopathy. The main histological finding was an increased number of abnormal mitochondria in tubular cells and podocytes. Analysis of mitochondrial DNA from leukocytes and urine sediment revealed heteroplasmy for the A3243G mutation in tRNAleu(UUR) gene in both patients. Recognition of the characteristic clinical and histological features of the mitochondrial A3243G mutation-associated glomerulopathy will enable correct diagnosis and better management of a disease which is likely to be underdiagnosed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356973     DOI: 10.5414/cnp62149

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

1.  Deletion of the Mitochondrial Complex-IV Cofactor Heme A:Farnesyltransferase Causes Focal Segmental Glomerulosclerosis and Interferon Response.

Authors:  Jea-Hyun Baek; Ivan G Gomez; Yukihiro Wada; Allie Roach; Don Mahad; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2018-09-28       Impact factor: 4.307

2.  Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease.

Authors:  Juanjuan Zhao; Katherine Lupino; Benjamin J Wilkins; Chengxiang Qiu; Jian Liu; Yasuhiro Omura; Amanda L Allred; Caitlin McDonald; Katalin Susztak; Grant D Barish; Liming Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease.

Authors:  William J He; Changwei Li; Zhijie Huang; Siyi Geng; Varun S Rao; Tanika N Kelly; L Lee Hamm; Morgan E Grams; Dan E Arking; Lawrence J Appel; Casey M Rebholz
Journal:  Clin J Am Soc Nephrol       Date:  2022-07       Impact factor: 10.614

Review 4.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

Review 5.  The Emerging Role of Mitochondrial Targeting in Kidney Disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Handb Exp Pharmacol       Date:  2017

6.  Progress in pathogenesis of proteinuria.

Authors:  Aihua Zhang; Songming Huang
Journal:  Int J Nephrol       Date:  2012-05-24

Review 7.  New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease.

Authors:  José Pedraza-Chaverri; Laura G Sánchez-Lozada; Horacio Osorio-Alonso; Edilia Tapia; Alexandra Scholze
Journal:  Oxid Med Cell Longev       Date:  2016-06-27       Impact factor: 6.543

8.  PUS3 mutations are associated with intellectual disability, leukoencephalopathy, and nephropathy.

Authors:  Anderson Rodrigues Brandão de Paiva; David S Lynch; Uirá Souto Melo; Leandro Tavares Lucato; Fernando Freua; Bruno Della Ripa de Assis; Isabella Barcelos; Clarice Listik; Diego de Castro Dos Santos; Lúcia Inês Macedo-Souza; Henry Houlden; Fernando Kok
Journal:  Neurol Genet       Date:  2019-01-16

Review 9.  Mitochondrial DNA mutations in renal disease: an overview.

Authors:  Larissa P Govers; Hakan R Toka; Ali Hariri; Stephen B Walsh; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2020-01-10       Impact factor: 3.714

10.  Postlingual hearing loss as a mitochondrial 3243A>G mutation phenotype.

Authors:  Katarzyna Iwanicka-Pronicka; Agnieszka Pollak; Agata Skórka; Urszula Lechowicz; Magdalena Pajdowska; Mariusz Furmanek; Maciej Rzeski; Lech Korniszewski; Henryk Skarżyński; Rafał Płoski
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.